Article Text

Download PDFPDF

163 Lox-1-specific affimers block oxldl accumulation in vitro
  1. Jonathan De Siqueira,
  2. Izma Abdul Zani,
  3. David Russell,
  4. Stephen Wheatcroft,
  5. Darren Tomlinson,
  6. Shervanthi Homer-Vanniasinkam,
  7. Sreenivasan Ponnambalam
  1. University of Leeds
  2. LOX-1, oLDL, affimer


Introduction Lectin-like oxidised low density lipoprotein receptor 1 (LOX-1, SREC-1, OLR1) is a class E scavenger which binds oxidised low density lipoproteins (oxLDL). It is expressed on endothelial cells, macrophages and smooth muscle cells, where it has a major role in sensing oxLDL, in the triggering of cellular dysfunction and in contribution to atherosclerosis. LOX-1 is thus an important target for the prevention and/or treatment of atherosclerosis. Affimers are synthetic protein scaffolds containing two hypervariable amino acid loops which enable recognition of a wide range of molecules. We aimed to investigate whether affimers specific for LOX-1 could be used to target oxLDL recognition and uptake using an in vitro cellular model.

Methods Human embryonic kidney (HEK293T) and porcine aortic endothelial cells (PAEC) with tetracycline-inducible protein expression were engineered to expressed human LOX-1-FLAG construct. Isolated clonal lines for each cell type was checked using RT-PCR, immunoblotting and immunofluorescence microscopy. After overnight incubation with tetracycline (1 microgram/ml), cells were starved and incubated with=1,1‘-Dioctadecyl-3,3,3’,3’-Tetramethylindocarbocyanine Perchlorate (DiI)-labelled oxLDL (10 microgram/ml) for 30 min. Cells were fixed and imaged to characterise the uptake of OxLDL. Blocking experiments using 5 different affimers, was carried out by adding affimer prior to incubation with DiI-oxLDL. Effects on oxLDL binding and cellular accumulation was evaluated using fluorescence microscopy.

Results The levels of LOX-1-FLAG mRNA were significantly raised (p<0.001) in both cell types in response to tetracycline. Porcine endothelial cells also had significant levels of endogenous native porcine LOX-1(Figure 1). The presence of human LOX-1-FLAG protein was confirmed by immunofluorescence microscopy (Figure 2a). Incubation with oxLDL demonstrated tetracycline-dependent labelled lipid particle uptake in HEK293T LOX-1-FLAG expressing cells. In contrast, oxLDL uptake was not significantly raised compared to uninduced baseline in PAEC LOX-1-FLAG expressing cells. Incubation with LOX-1 binding affimers led to a decrease in oxLDL uptake in both cell lines after induction of LOX-1-FLAG expression (Figure 2b).

Conclusion We have successfully constructed two mammalian cell lines with a stable, inducible LOX-1 expression system. This has allowed us to demonstrate LOX-1-dependent oxLDL uptake. However, such expression is dependent on negligible expression of other scavenger receptors that mediate oxLDL binding and/or uptake. The use of LOX-1-specific affimers show that oxLDL binding and/or uptake is significantly decreased in both cell lines. Future experiments aim to determine the effects of such LOX-1-specific affimers in primary vascular cells and animal models in the context of atherosclerosis and vascular disease.

Abstract 163 Figure 1

Relative mRNA levels of: A) Human LOX-1 in HEKs, B) Human LOX-1 in PAECs and C) Porcine LOX-1 in PAECs

Abstract 163 Figure 2

Immunofluorescence Microscopy of HEK293T after induction with 1microgram/ml Tetracycline. A) Blue (DAPI) staining of nucleus and green (anti-FLAG) staining of FLAG-tagged LOX-1 B) Affimer effects on oxLDL (red) uptake.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.